New Cancer Pain Treatment Options

Purpose of Review

Cancer pain is often incapacitating and discouraging to patients; is demoralizing to family members and care takers; and is taxing and difficult to subdue for the pain specialists. The consequences of implementing suboptimal treatment are far-reaching; therefore, effective treatment methods are in a great demand. The face of cancer pain management has changed in considerable ways, and interventional procedures have become an integral part of providing multimodal analgesia in cancer pain treatment. The goals of this review are to draw attention to the critical role that regional anesthetic nerve blocks and interventional pain management techniques play in treating malignancy-related pain and emphasize the benefits provided by the aforementioned treatment strategies.

Recent Findings

A large proportion of cancer patients continues to struggle with an inadequately treated pain despite a strict adherence to the WHO analgesic step ladder. The previous pain treatment algorithm has been modified to include peripheral neural blockade, neuro-destructive techniques, neuromodulatory device use, and intrathecal drug delivery systems. The accumulated evidence highlights the opioid-sparing qualities and other benefits afforded by these modalities: decreasing medication-induced side effects, reducing economic burden of poor analgesia, and overall improvement in quality of life of the patients afflicted with a painful neoplastic disease.

Summary

The rising prevalence of cancer-related pain syndromes is paralleled by an unmatched growth of innovative treatment strategies. Modified WHO analgesic ladder represents one of the greatest paradigm shifts within the domain of oncologic pain treatment. The cancer patient population requires a prompt and liberal, albeit judicious, delivery of unorthodox pain treatment options freed from the rigid bonds of conventional guidelines and standard practices.

     

Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders

Neuromyelitis optica spectrum disorders (NMOSD) are associated with anti-aquaporin-4 autoantibodies (AQP4-IgG). Limited data is available on longitudinal cerebrospinal fluid (CSF) AQP4-IgG and their relation to disease activity and inflammatory parameters. AQP4-IgG titers were measured in matched longitudinal serum and CSF samples of 12 patients with NMOSD by an immunofluorescence assay and correlated with clinical parameters. CSF AQP4-IgG were present in patients with high serum titers and correlated with spinal MRI lesion length and CSF parameters. Clinical improvement was associated with a decrease in CSF, but not serum, AQP4-IgG titers. Thus, CSF AQP4-IgG were associated with clinical activity and neuroinflammation.     

Distribution of normal and pathological OGTTs among pregnant population and non-pregnant women with PCOS – the cross-sectional study

Both pregnancy, as physiological, and polycystic ovary syndrome (PCOS), as a pathological condition, carry the risk for developing glucose metabolism abnormalities. In this retrospective cross-sectional study, we hypothesized that pregnancy as a physiological condition carries a higher likelihood for abnormal oral glucose tolerance test (OGTT) results than PCOS as a pathological condition.We have compared the prevalence and likelihood ratios for abnormal OGTT results between non-pregnant women with PCOS (Group A) and pregnant women at 24 to 28 weeks of gestation (Group B). Participants of both study groups underwent glucose tolerance testing with 75 g glucose OGTT. During the study period, 7411 women were tested, 3932 women encompassed Group A, and 3479 women comprised Group B.The numbers of yearly tested pregnant women and the corresponding proportion of tested women among all study participants have decreased during the study period, from 766 to 131 and 89.1% to 20.5%, respectively. Group A had a significantly lower prevalence (4.4%) of pathological OGTT results compared to Group B (8.1%). This has resulted in a 45.427 likelihood ratio (P < .001) for abnormal OGTT results in pregnant women compared to non-pregnant women with PCOS.We might conclude that pregnancy could have a more challenging influence on glucose metabolism and that carries higher risks for abnormal glucose metabolism than PCOS. The awareness of obstetricians regarding physiological changes during pregnancy that predisposes abnormal glucose metabolism is decreasing over time and the compliance concerning OGTT testing of pregnant women is decreasing too.     

Impact of various luting cements on the fixed dentures bonding strength

BACKGROUND/AIM: Various luting cements are used to fix dental crowns to prepared teeth, and should provide an adhesive bond to the tooth structure giving reliable retention. The aim of this study was to establish in vitro which type of the tested luting cement provided the strongest adhesive bond of the prepared teeth to the fixed denture. METHODS: Testing was carried out on the sample of 100 intact human premolars extracted for orthodontic reasons. The preparation of the teeth was performed by a heavy-duty machine. The surfaces of the prepared teeth were mathematically calculated. Dental crowns from the Nickel-Chromium-Molybenum (Ni-Cr-Mo) alloy were made in a standard fashion, and fixed to prepared teeth (two samples of each group) with 5 different types of luting cements. The strength of force applyed to separate the cast crowns from the prepared teeth was measured by an electronic dynamometer, after 7 days. RESULTS: The obtained results revealed the connection between the type of luting cement and the values of retention power. The best adhesive bond under the constant convergence angle of the prepared teeth was provided by the resin cement. CONCLUSION: When choosing a luting cement for fixing dental crowns to prepared teeth, the advantage should be given to the resin cement in case the glassionomers are not available.     

Verbal memory impairment in children with focal epilepsy

Findings of both material- and hemisphere-specific influence on memory performance in children with epilepsy are inconsistent. Verbal memory of 80 children with focal epilepsy, aged 7 to 16, was assessed and compared with verbal memory of 80 healthy schoolchildren. The Verbal Selective Reminding test was used to distinguish between patients with left-sided (N=38) and patients with right-sided (N=42) electroencephalographic focal abnormalities. In addition, groups with temporal (N=36) and extratemporal (N=44) focal epilepsy were compared. Effects of seizure-related variables were also assessed. Children with focal epilepsy scored significantly lower on tests when compared with the healthy group. Lateralization of the EEG focus was not found to significantly affect verbal memory performance. Only the CLTR component of the Verbal Selective Reminding test was susceptible to lateralization and localization effects. Differences between the group with left and the group with right temporal epilepsy (P<0.03) and between the group with temporal and the group with extratemporal epilepsy (P<0.01) reached statistical significance.